Description
Kemocrab 450 mg contains Carboplatin, a second-generation platinum compound widely used in combination chemotherapy regimens. It is administered intravenously in hospital or oncology settings.
🔬 Mechanism of Action
Carboplatin forms cross-links within DNA strands in cancer cells. As a result:
- DNA replication is inhibited
- Cancer cell division is disrupted
- Tumor growth slows or stops
Because it targets rapidly dividing cells, it is effective against multiple solid tumors.
💊 Indications
Kemocrab 450 mg is indicated for:
- Ovarian Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Head and Neck Cancers
- Other solid tumors as part of combination chemotherapy
📌 Key Features of Kemocrab 450 mg
- Strength: 450 mg
- Dosage Form: Intravenous injection/infusion
- Therapeutic Class: Platinum-Based Chemotherapy Agent
- Administration: IV infusion under strict medical supervision
- Dosing: Calculated based on body surface area (BSA) or AUC formula
- Monitoring: Regular complete blood count (CBC) and kidney function tests required
⚕️ Benefits of Carboplatin
- Effective against various solid tumors
- Commonly used in combination therapy
- Lower nephrotoxicity compared to cisplatin
- Established role in oncology treatment protocols
⚠️ Precautions
- Risk of bone marrow suppression (anemia, neutropenia, thrombocytopenia)
- Nausea and vomiting may occur
- Kidney function monitoring required
- Hypersensitivity reactions possible
- Use strictly under oncologist supervision
Kemocrab 450 mg (Carboplatin Injection) is a trusted platinum-based chemotherapy agent used in modern cancer treatment regimens, helping control tumor growth and improve patient outcomes when administered under specialized oncology care.
